ArticleESMO real world data and digital oncology2026
Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study.
A Fagotti et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.